Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E26.13 EPS (ttm)5.58 Insider Own0.08% Shs Outstand2.63B Perf Week-2.36%
Market Cap380.89B Forward P/E16.11 EPS next Y9.04 Insider Trans-2.04% Shs Float2.63B Perf Month-4.36%
Income14.89B PEG5.13 EPS next Q1.96 Inst Own70.30% Short Float0.39% Perf Quarter5.70%
Sales80.50B P/S4.73 EPS this Y0.50% Inst Trans-0.84% Short Ratio1.68 Perf Half Y18.27%
Book/sh23.92 P/B6.09 EPS next Y14.91% ROA9.70% Target Price165.06 Perf Year13.05%
Cash/sh7.32 P/C19.91 EPS next 5Y5.09% ROE25.10% 52W Range109.16 - 157.00 Perf YTD-0.14%
Dividend4.04 P/FCF52.32 EPS past 5Y-0.20% ROI17.30% 52W High-5.92% Beta0.69
Dividend %2.77% Quick Ratio1.00 Sales past 5Y2.00% Gross Margin65.80% 52W Low35.31% ATR2.85
Employees132200 Current Ratio1.20 Sales Q/Q-10.80% Oper. Margin20.30% RSI (14)49.82 Volatility1.96% 2.03%
OptionableYes Debt/Eq0.48 EPS Q/Q-34.70% Profit Margin18.90% Rel Volume0.73 Prev Close145.66
ShortableYes LT Debt/Eq0.40 Earnings- Payout66.90% Avg Volume6.12M Price147.70
Recom1.90 SMA20-0.48% SMA50-0.75% SMA2001.78% Volume1,765,737 Change1.40%
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Sep-28-20 10:43AM  
Sep-27-20 07:29AM  
07:00AM  
Sep-26-20 07:07AM  
04:21AM  
Sep-25-20 05:47PM  
04:42PM  
04:25PM  
02:54PM  
02:44PM  
01:30PM  
12:58PM  
12:23PM  
10:39AM  
10:02AM  
10:00AM  
09:07AM  
06:03AM  
Sep-24-20 06:45PM  
04:25PM  
04:14PM  
03:14PM  
12:14PM  
11:34AM  
11:33AM  
10:19AM  
09:58AM  
07:54AM  
07:53AM  
07:44AM  
06:36AM  
02:21AM  
01:38AM  
Sep-23-20 08:33PM  
08:19PM  
04:47PM  
04:26PM  
04:25PM  
04:20PM  
03:26PM  
02:41PM  
02:13PM  
01:33PM  
01:29PM  
01:28PM  
11:58AM  
11:45AM  
11:39AM  
11:06AM  
10:52AM  
10:51AM  
10:45AM  
10:19AM  
09:59AM  
09:47AM  
09:45AM  
09:33AM  
09:18AM  
08:52AM  
08:20AM  
06:56AM  
06:45AM  
06:45AM  
Sep-22-20 05:45PM  
04:25PM  
Sep-21-20 04:27PM  
04:25PM  
02:04PM  
10:42AM  
09:00AM  
Sep-20-20 06:09AM  
Sep-18-20 04:25PM  
04:19PM  
03:57PM  
03:12PM  
12:50PM  
11:12AM  
10:26AM  
09:51AM  
09:26AM  
08:45AM  
08:04AM  
06:08AM  
05:31AM  
Sep-17-20 10:06PM  
05:48PM  
05:27PM  
05:02PM  
04:54PM  
04:25PM  
03:29PM  
11:21AM  
11:06AM  
Sep-16-20 04:25PM  
02:04PM  
06:08AM  
Sep-15-20 05:45PM  
03:49PM  
12:27PM  
11:58AM  
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Option Exercise63.7516,1151,027,32374,535Sep 04 02:58 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Sale153.5216,1152,473,93858,420Sep 04 02:58 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesJul 28Sale147.4729,0004,276,63021,682Jul 28 06:43 PM
JOHNSON & JOHNSON10% OwnerJun 30Buy17.00725,00012,325,0003,670,516Jul 02 04:58 PM
PEREZ WILLIAM DDirectorMar 13Buy127.6950063,84316,030Mar 17 04:24 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Option Exercise90.4419,2241,738,61975,039Feb 25 04:23 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Sale147.9639,2245,803,58335,815Feb 25 04:23 PM
Ullmann Michael HExec VP, General CounselFeb 13Option Exercise0.0020,3260152,697Feb 18 05:03 PM
Wolk Joseph JExec VP, CFOFeb 13Option Exercise0.007,080021,387Feb 18 05:03 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 13Option Exercise0.0015,809065,532Feb 18 05:03 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13Option Exercise0.0022,2310110,559Feb 18 05:03 PM
Decker Robert JController, CAOFeb 13Option Exercise0.001,499013,946Feb 18 05:03 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 13Option Exercise0.00105,6680220,373Feb 18 05:03 PM
Gorsky AlexChairman, CEOFeb 13Option Exercise0.00107,0160496,472Feb 18 05:03 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 13Option Exercise0.0013,747056,496Feb 18 05:03 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 13Option Exercise0.003,692057,259Feb 18 05:03 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 13Option Exercise0.0011,836061,219Feb 18 05:03 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 13Option Exercise0.0039,3810270,900Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 13Option Exercise0.0016,0840115,813Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 03Option Exercise0.0048,3120123,450Feb 04 07:31 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 03Option Exercise0.0038,650058,154Feb 04 07:31 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Option Exercise62.6258,1283,639,975107,511Feb 03 06:28 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Sale149.3958,1288,683,56849,383Feb 03 06:28 PM
Joly HubertDirectorDec 13Buy141.285,000706,3995,000Dec 16 04:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Option Exercise62.622,017126,30551,736Dec 16 05:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Sale141.072,017284,53849,719Dec 16 05:40 PM